11:45 am Utilizing Non-Invasive Biomarkers, Including Blood-Based Biomarkers, to Improve MASH Diagnosis & Prognosis for Alternatives to Liver Biopsies
Time: 11:45 am
day: Conference Day 1
Details:
- Improving MASH diagnosis using the application of non-invasive biomarkers to enhance early detection and accurate disease characterization to facilitate timely intervention and personalized treatment strategies
- Enhancing prognosis prediction using non-invasive biomarker analysis to more accurately assess disease progression and risk stratification to guide clinical decision-making and optimize patient management
- Replacing liver biopsies with non-invasive biomarker alternatives to offer a way to avoid invasive procedures to increase patient comfort and safety
